Published: Dec 12, 2020, 02:35 IST | Updated: Dec 12, 2020, 02:35 IST
In India, the head of the Serum Institute which has tasked to develop the AstraZeneca based Covishield vaccine in the country now says, that the positive late state trial results of the candidates will allow it to seek emergency use approval by the year end.